Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No.   Description

10.1            Co-Promotion Agreement, dated October 4, 2022, between Provention
              Bio, Inc. and Genzyme Corporation.

10.2            Securities Purchase Agreement, dated October 4, 2022, between
              Provention Bio, Inc. and Aventis Inc.

99.1            Press Release issued by Provention Bio, Inc. on October 6, 2022
              (incorporated by reference to the Original Filing).

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses